(BTI) British American Tobacco - Ratings and Ratios
Cigarettes, Vapour, Heated, Oral, Snus
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.43% |
| Yield on Cost 5y | 11.68% |
| Yield CAGR 5y | 0.10% |
| Payout Consistency | 89.1% |
| Payout Ratio | 2.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.8% |
| Value at Risk 5%th | 32.4% |
| Relative Tail Risk | -5.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.05 |
| Alpha | 54.56 |
| CAGR/Max DD | 1.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.499 |
| Beta | 0.062 |
| Beta Downside | 0.085 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.82% |
| Mean DD | 7.81% |
| Median DD | 7.34% |
Description: BTI British American Tobacco December 02, 2025
British American Tobacco p.l.c. (NYSE: BTI) is a global tobacco and nicotine company that markets a broad portfolio-including combustible cigarettes, vapour, heated-tobacco, and modern oral nicotine products-through well-known brands such as Vuse, glo, Velo, Camel, Dunhill and Lucky Strike. Its distribution network spans the Americas, Europe, Asia-Pacific, the Middle East, Africa and the United States, and the firm is headquartered in London, United Kingdom.
Key recent metrics: FY 2023 net revenue was $27.3 billion, with an adjusted operating margin of 31 %-the highest in the sector, driven largely by a ~15 % share of next-generation products (NGPs) in total sales, which grew ≈ 20 % YoY. The company’s free-cash-flow conversion remains above 70 %, supporting its £2 billion annual dividend. Sector-level drivers include declining smoking prevalence in high-income markets (≈ −2 % p.a.) and tightening regulation, which is accelerating the shift toward higher-margin NGPs and price-elastic premium pricing strategies.
For a deeper, data-rich assessment of BTI’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.75b TTM) > 0 and > 6% of Revenue (6% = 3.11b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 6.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.10% (prev -4.31%; Δ 0.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 16.29b > Net Income -10.75b (YES >=105%, WARN >=100%) |
| Net Debt (-4.40b) to EBITDA (20.68b) ratio: -0.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.21b) change vs 12m ago -1.14% (target <= -2.0% for YES) |
| Gross Margin 82.49% (prev 73.90%; Δ 8.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.23% (prev 29.04%; Δ 16.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.79 (EBITDA TTM 20.68b / Interest Expense TTM 4.30b) >= 6 (WARN >= 3) |
Altman Z'' 2.29
| (A) -0.02 = (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b |
| (B) 0.21 = Retained Earnings (Balance) 22.99b / Total Assets 110.23b |
| (C) 0.14 = EBIT TTM 16.31b / Avg Total Assets 114.47b |
| (D) 0.74 = Book Value of Equity 46.75b / Total Liabilities 63.05b |
| Total Rating: 2.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.54
| 1. Piotroski 5.50pt |
| 2. FCF Yield 15.32% |
| 3. FCF Margin 36.14% |
| 4. Debt/Equity 0.75 |
| 5. Debt/Ebitda -0.21 |
| 6. ROIC - WACC (= 21.68)% |
| 7. RoE -20.99% |
| 8. Rev. Trend 55.30% |
| 9. EPS Trend 13.29% |
What is the price of BTI shares?
Over the past week, the price has changed by -2.40%, over one month by -2.38%, over three months by +8.89% and over the past year by +63.51%.
Is BTI a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.5 | 7.8% |
| Analysts Target Price | 59.5 | 7.8% |
| ValueRay Target Price | 70.8 | 28.3% |
BTI Fundamental Data Overview January 04, 2026
P/E Trailing = 30.0798
P/E Forward = 11.4811
P/S = 4.7994
P/B = 1.9487
P/EG = 0.4017
Beta = 0.06
Revenue TTM = 51.78b GBP
EBIT TTM = 16.31b GBP
EBITDA TTM = 20.68b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 122.15b GBP (91.23b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 3.79 (Ebit TTM 16.31b / Interest Expense TTM 4.30b)
EV/FCF = 6.53x (Enterprise Value 122.15b / FCF TTM 18.71b)
FCF Yield = 15.32% (FCF TTM 18.71b / Enterprise Value 122.15b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.11 (Enterprise Value 122.15b / Total Assets 110.23b)
Interest Expense / Debt = 2.16% (Interest Expense 764.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.36b (EBIT 16.31b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.68b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.39% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.63% (EBIT 16.31b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.60% (NOPAT 13.36b / Invested Capital 50.21b)
WACC = 4.92% (E(91.23b)/V(126.55b) * Re(6.14%) + D(35.33b)/V(126.55b) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.93%
[DCF Debug] Terminal Value 87.27% ; FCFF base≈16.22b ; Y1≈17.92b ; Y5≈23.17b
Fair Price DCF = 316.8 (EV 683.71b - Net Debt -4.40b = Equity 688.12b / Shares 2.17b; r=5.90% [WACC]; 5y FCF grow 12.09% → 2.90% )
EPS Correlation: 13.29 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 55.30 | Revenue CAGR: -2.95% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=4.88 | Chg30d=+0.015 | Revisions Net=-2 | Growth EPS=+5.9% | Growth Revenue=+3.0%
Additional Sources for BTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle